By: WeedClub Team, Friday, February 7, 2020 at 9:17 AM PT
New research from doctors indicates that there is evidence of CBD being an effective way to normalize the psychological health of psychosis patients.
Administering a (600 mg) Dose or a placebo was used in the study, along with MRI scans and other tools. Researchers measured possible effects on the mediotemporal and pre-frontal activity and mediotemporal-striatal connectivity in the study. Researchers' reports were just published on the National Center for Biotechnology Information, U.S. National Library of Medicine website.
Is it ironic that more and more research is breaking on official government websites, yet weed is still a Schedule I Drug? For a plant with "no medical benefit", there sure are a lot of medical uses for the base ingredients in cannabis: Cannabinoids.
Scientists are still discovering new cannabinoids, while researching applications utilizing known cannabinoids in the marijuana genome.
Back to this groundbreaking research on how CBD is working to affect pschotic health: scientists determined in their conclusions that: "This suggests that normalization of mediotemporal and prefrontal dysfunction and mediotemporal-striatal functional connectivity may underlie the antipsychotic effects of CBD."
We need to finally unravel the medical potential of every single chemical and chemical combination derived from cannabis and its extracts. Prohibition delayed relief for many patients throughout the world. Descheduling marijuana is long overdue and it should have never been classified as a Schedule I drug in the first place.
Please login above to comment.